WHO and the Finance and Access Working Group are pleased to share this working draft of the landscape and evidence to date as a public summary for consultation. Please note that it remains an interim version and will be finalized after receiving and reviewing collective comments.
This landscape and evidence to date report will form part of a broader report that will include proposed solutions by the F&A WG to accelerate equitable access and sustainable financing to novel TB vaccines. The final report is expected to be published on 6 November 2025.
The purpose of the public summary for consultation is to gather feedback from key stakeholders as the work is finalized. By publishing this public summary in advance of the final report, WHO and its partners reaffirm commitments to inclusive engagement, transparency and accountability, ensuring that civil society and key stakeholders can inform the shared understanding that will shape the path to equitable access to novel TB vaccines.
The ‘Landscape and Evidence to date’ is for review, the ‘Annexes’ are for information. Please provide feedback by filling in the Feedback Submission Form and emailing it to the contact details provided in the form, by COB 28 September 2025.